ICER publishes final framework for Orphan Drug assessment

The Institute for Clinical and Economic Review published its final value framework to be applied in the assessment of Orphan Drugs for serious ultra-rare conditions. The modifications to the framework are in line with the proposed changes the institute outlined in July (see BioCentury Extra, July 26)...